Advanced PFAS Pace Analytical Services recently launched a testing method for ultrashort-chain PFAS, signaling a capability to address emerging contaminants that many industries must monitor. This opening creates cross-sell opportunities with clients in environmental consulting, manufacturing, and public sectors seeking up-to-date PFAS analytics.

Pharma CRO/CDMO With Pace Life Sciences offering full-service CDMO/CRO capabilities across a nationwide network and FDA-registered labs, there is strong potential to upsell pharmaceutical and biopharmaceutical clients to expanded services such as formulation development, batch manufacturing support, and stability studies through Aspirebiolabs collaboration.

Expansion & Capacity Recent investments in life sciences laboratories and two new labs indicate growing capacity to serve pharmaceutical and biopharma customers. This enables targeted outreach to larger biotech accounts requiring scalable analytical support, regulatory compliance, and faster turnaround times.

Strategic Leadership Executive leadership changes and a new Director of R&D signal a strategic push toward innovation and expanded capabilities. Leverage this to position Pace as a partner for new projects, pilot programs, and long-term collaborations in testing methods, method development, and regulatory-ready data services.

Awards & Partnerships Environmental Business Journal award for Respirable Crystalline Silica testing and recent partnership with Aspire Biolabs highlight credibility and cross-industry collaboration. Target construction, environmental health, and life sciences customers who value validated methods, compliance, and joint go-to-market opportunities.